| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |